In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer’s Disease Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|15|5|624-628

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.15, Iss.5, 2016-05, pp. : 624-628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Silico Studies of (2E,5E)-2,5-bis(3-methoxy-4-hydroxy-benzylidene) Cyclopentanone on Proteins AChE and BChE Involved in Alzheimer's disease and Ameliorative Effects on Paraquat Induced Oxidative Stress Markers in Drosophila melanogaster

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 3, 2011-03 ,pp. : 260-267

Bentham Science Publishers

Access to resources Recommend Favorite

Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy

By  

Current Neuropharmacology, Vol. 11, Iss. 4, 2013-07 ,pp. : 388-413

Bentham Science Publishers

Access to resources Recommend Favorite

Common SAR Derived from Linear and Non-linear QSAR Studies on AChE Inhibitors used in the Treatment of Alzheimer#39;s Disease

By  

Current Neuropharmacology, Vol. 15, Iss. 8, 2017-11 ,pp. : 1093-1099

Bentham Science Publishers

Access to resources Recommend Favorite

New Classes of AChE Inhibitors with Additional Pharmacological Effects of Interest for the Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 25, 2004-10 ,pp. : 3177-3184

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

By Jönsson L.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite